Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
18,31 USD | +0,88% |
|
-4,59% | +7,20% |
Attività
Numero di dipendenti: 284
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Novel Treatments for B-cell Diseases
100,0
%
| 3 | 100,0 % | 234 | 100,0 % | +8.290,02% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 3 | 100,0 % | 234 | 100,0 % | +8.290,02% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 58 | 18/05/93 |
Sean Power
DFI | Director of Finance/CFO | 42 | 29/12/11 |
Jenna A. Bosco
IRC | Investor Relations Contact | - | 01/12/11 |
Adam Waldman
PRN | Corporate Officer/Principal | - | 04/06/18 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Michael Weiss
CEO | Chief Executive Officer | 58 | 18/05/93 |
Laurence Charney
BRD | Director/Board Member | 76 | 01/03/12 |
Kenneth Hoberman
BRD | Director/Board Member | 59 | 15/12/14 |
Yann Echelard
BRD | Director/Board Member | 60 | 09/11/12 |
Daniel Hume
BRD | Director/Board Member | 57 | 01/04/15 |
Sagar Lonial
BRD | Director/Board Member | 57 | 29/04/20 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 154 584 254 | 139 779 168 ( 90,42 %) | 41 309 ( 0,0267 %) | 90,42 % |
Coordinate società
TG Therapeutics, Inc.
3020 Carrington Mill Boulevard Suite 475
27560, Morrisville
+212 554 4484
http://www.tgtherapeutics.com![Indirizzo TG Therapeutics, Inc.(TGTX)](https://cdn.zonebourse.com/static/address/13314736.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+7,20% | 2,62 Mrd | |
+17,72% | 44,87 Mrd | |
-10,33% | 37,8 Mrd | |
+42,38% | 37,61 Mrd | |
+29,36% | 31,32 Mrd | |
-8,44% | 27,4 Mrd | |
+12,45% | 26,32 Mrd | |
+44,19% | 14,07 Mrd | |
+31,93% | 12,5 Mrd | |
-7,67% | 11,23 Mrd |
- Borsa valori
- Azioni
- Azione TGTX
- Società TG Therapeutics, Inc.